Arke Estudios Clínicos S.A. de C.V. - Ciudad de México

Cozumel 90, Roma Nte., Cuauhtémoc, 06700 Ciudad de México

Select an option

I am a doctor

I am a sponsor

Open studies

Lung cancer

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1% - RELATIVITY1093 - Bristol-Myers SquibbSee more

A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004) - MK-1084-004 - KANDLELIT-004 - Merck Sharp & Dohme LLCSee more